CANC
CVS icon

Culbertson A N & Co’s CVS Health CVS Stock Holding History

Culbertson A N & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.49M Sell
34,704
-3,930
-10% -$303K 0.32% 68
2025
Q4 		$3.07M Sell
38,634
-1,580
-4% -$125K 0.42% 58
2025
Q3 		$3.03M Buy
40,214
+5,223
+15% +$358K 0.43% 57
2025
Q2 		$2.41M Sell
34,991
-629
-2% -$41.2K 0.37% 63
2025
Q1 		$2.41M Sell
35,620
-3,247
-8% -$194K 0.39% 62
2024
Q4 		$1.74M Sell
38,867
-9,599
-20% -$539K 0.28% 76
2024
Q3 		$3.05M Sell
48,466
-26,527
-35% -$1.55M 0.49% 54
2024
Q2 		$4.43M Sell
74,993
-9,035
-11% -$565K 0.77% 39
2024
Q1 		$6.7M Sell
84,028
-4,765
-5% -$364K 1.16% 27
2023
Q4 		$7.01M Sell
88,793
-1,085
-1% -$77.2K 1.3% 26
2023
Q3 		$6.28M Buy
89,878
+42
+0% +$2.98K 1.26% 27
2023
Q2 		$6.21M Sell
89,836
-510
-0.6% -$36.3K 1.2% 28
2023
Q1 		$6.71M Buy
90,346
+127
+0.1% +$10.7K 1.37% 26
2022
Q4 		$8.41M Sell
90,219
-1,615
-2% -$156K 1.77% 18
2022
Q3 		$8.76M Sell
91,834
-2,520
-3% -$249K 2.03% 11
2022
Q2 		$8.74M Sell
94,354
-500
-0.5% -$48.8K 1.9% 12
2022
Q1 		$9.6M Sell
94,854
-720
-0.8% -$75.6K 1.81% 14
2021
Q4 		$9.86M Sell
95,574
-2,621
-3% -$242K 1.86% 14
2021
Q3 		$8.33M Buy
98,195
+14
+0% +$1.17K 1.71% 16
2021
Q2 		$8.19M Buy
98,181
+116
+0.1% +$9.5K 1.71% 17
2021
Q1 		$7.38M Buy
98,065
+1,940
+2% +$141K 1.62% 20
2020
Q4 		$6.57M Sell
96,125
-2,625
-3% -$171K 1.56% 19
2020
Q3 		$5.77M Buy
98,750
+1,500
+2% +$93.3K 1.52% 19
2020
Q2 		$6.32M Buy
97,250
+70
+0.1% +$4.41K 1.74% 14
2020
Q1 		$5.77M Sell
97,180
-1,719
-2% -$115K 1.87% 13
2019
Q4 		$7.35M Sell
98,899
-4,495
-4% -$316K 1.89% 14
2019
Q3 		$6.52M Buy
103,394
+151
+0.1% +$8.95K 1.78% 13
2019
Q2 		$5.63M Buy
103,243
+750
+0.7% +$40.4K 1.56% 23
2019
Q1 		$5.53M Sell
102,493
-810
-0.8% -$50K 1.59% 20
2018
Q4 		$6.77M Sell
103,303
-1,923
-2% -$144K 2.16% 14
2018
Q3 		$8.28M Buy
105,226
+200
+0.2% +$14.3K 2.26% 9
2018
Q2 		$6.76M Sell
105,026
-408
-0.4% -$26.9K 2.01% 16
2018
Q1 		$6.56M Sell
105,434
-2,750
-3% -$197K 1.96% 17
2017
Q4 		$7.84M Sell
108,184
-2,000
-2% -$145K 2.21% 13
2017
Q3 		$8.96M Buy
110,184
+1,218
+1% +$96.3K 2.73% 7
2017
Q2 		$8.77M Sell
108,966
-506
-0.5% -$40K 2.78% 6
2017
Q1 		$8.59M Buy
109,472
+1,603
+1% +$128K 2.8% 6
2016
Q4 		$8.51M Sell
107,869
-225
-0.2% -$18.2K 2.9% 5
2016
Q3 		$9.62M Sell
108,094
-505
-0.5% -$47.7K 3.42% 3
2016
Q2 		$10.4M Sell
108,599
-507
-0.5% -$50.5K 3.85% 2
2016
Q1 		$11.3M Sell
109,106
-50
-0% -$4.86K 4.39% 2
2015
Q4 		$10.7M Buy
109,156
+2,547
+2% +$249K 4.22% 2
2015
Q3 		$10.3M Sell
106,609
-449
-0.4% -$47.2K 4.34% 2
2015
Q2 		$11.2M Buy
107,058
+1,672
+2% +$171K 4.38% 2
2015
Q1 		$10.9M Sell
105,386
-513
-0.5% -$51.9K 4.33% 2
2014
Q4 		$10.2M Sell
105,899
-875
-0.8% -$77.1K 4.21% 2
2014
Q3 		$8.5M Buy
106,774
+710
+0.7% +$56K 3.66% 2
2014
Q2 		$7.99M Buy
106,064
+1,332
+1% +$101K 3.48% 2
2014
Q1 		$7.84M Buy
104,732
+1,615
+2% +$114K 3.65% 2
2013
Q4 		$7.38M Buy
103,117
+450
+0.4% +$28.9K 3.59% 2
2013
Q3 		$5.83M Buy
102,667
+1,590
+2% +$94.7K 3.12% 4
2013
Q2 		$5.78M Buy
+101,077
New +$5.86M 3.25% 4

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Culbertson A N & Co's CVS Position: Q1 2026 in Review

Culbertson A N & Co reduced its CVS Health (CVS) stake by 10% in Q1 2026, selling an estimated $303K and leaving 34,704 shares worth $2.49M. The position accounts for 0.32% of the portfolio, ranked #68.

Culbertson A N & Co first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.3M in Q1 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Culbertson A N & Co held 34,704 shares of CVS Health worth $2.49M as of Q1 2026.
  • Culbertson A N & Co sold 3,930 CVS Health shares in Q1 2026, an estimated $303K.
  • CVS Health made up 0.32% of Culbertson A N & Co's portfolio in Q1 2026, its #68 holding.
  • Culbertson A N & Co first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Culbertson A N & Co's CVS Health position peaked at $11.3M in Q1 2016.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Culbertson A N & Co's 13F filing for Q1 2026, filed 12 May 2026.